Updated Jul 16, 2026
Duarte Ira has filed 3 SEC Form 4 filings across 1 company in the last 90 days.
Ira Duarte is the Executive Vice President and Chief Financial Officer at Heron Therapeutics, Inc., a biotechnology company focused on developing treatments for unmet patient needs. He has been involved in various SEC filings related to his role at the company.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | HRTX | HERON THERAPEUTICS, INC. /DE/ | F — Tax withholding / forfeiture | 3.6K | $0.38 | $1K |
| 2026-06-17 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 12.5K | — | |
| 2026-05-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 13.5K | — | |
| 2026-05-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 11.7K | — | |
| 2026-04-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 3.9K | — | |
| 2026-02-03 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 11.7K | — | |
| 2026-01-20 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 3.9K | — | |
| 2025-11-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 11.7K | — | |
| 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 3.9K | — | |
| 2024-10-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 3.9K | — |
Ira Duarte is the Executive Vice President and Chief Financial Officer at Heron Therapeutics, Inc., a biotechnology company focused on developing treatments for unmet patient needs. He has been involved in various SEC filings related to his role at the company.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Duarte Ira profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.